# Sling vs Botox for Mixed Incontinence

> **NCT04171531** · PHASE3 · COMPLETED · sponsor: **NICHD Pelvic Floor Disorders Network** · enrollment: 150 (actual)

## Conditions studied

- Urinary Incontinence, Stress
- Urinary Incontinence, Urge

## Interventions

- **DRUG:** Botox® injection
- **DEVICE:** Mid-urethral sling

## Key facts

- **NCT ID:** NCT04171531
- **Lead sponsor:** NICHD Pelvic Floor Disorders Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-08
- **Primary completion:** 2024-02-12
- **Final completion:** 2024-02-12
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2025-06-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04171531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04171531, "Sling vs Botox for Mixed Incontinence". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04171531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*